Sutro Biopharma (NASDAQ:STRO – Get Free Report)‘s stock had its “buy” rating reaffirmed by research analysts at Truist Financial in a report released on Thursday,Benzinga reports. They presently have a $50.00 target price on the stock. Truist Financial’s target price would suggest a potential upside of 91.64% from the company’s previous close. A number of […]

Five Below (NASDAQ:FIVE – Get Free Report)‘s stock had its “buy” rating restated by equities research analysts at Loop Capital in a research report issued to clients and investors on Thursday,Benzinga reports. They currently have a $250.00 price objective on the specialty retailer’s stock. Loop Capital’s price objective suggests a potential upside of 29.74% from […]

Veru (NASDAQ:VERU – Get Free Report)‘s stock had its “buy” rating reiterated by Canaccord Genuity Group in a research note issued on Thursday,Benzinga reports. They currently have a $25.00 price objective on the stock. Canaccord Genuity Group’s target price points to a potential upside of 370.19% from the stock’s current price. VERU has been the […]